These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20973248)

  • 1. [Risk factor control in peripheral arterial disease can be improved. Registry study of secondary prophylactic drug therapy].
    Alhadad A; Wiktorsson C; Lindblad B; Gottsäter A
    Lakartidningen; 2010 Sep 29-Oct 5; 107(39):2322-5. PubMed ID: 20973248
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacologic risk factor treatment of peripheral arterial disease is lacking and requires vascular surgeon participation.
    Bianchi C; Montalvo V; Ou HW; Bishop V; Abou-Zamzam AM
    Ann Vasc Surg; 2007 Mar; 21(2):163-6. PubMed ID: 17349357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regarding "Pharmacologic risk factor management in peripheral arterial disease: a vade mecum for vascular surgeons".
    Paraskevas KI
    J Vasc Surg; 2008 Sep; 48(3):776-7; author reply 777. PubMed ID: 18727983
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacologic risk factor management in peripheral arterial disease: a vade mecum for vascular surgeons.
    Rehring TF; Stolcpart RS; Hollis HW;
    J Vasc Surg; 2008 May; 47(5):1108-15. PubMed ID: 18372155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of baseline cardiovascular risk factors in the SU-FOL-OM3 study cohort: does the localization of the arterial event matter?
    Vesin C; Galan P; Gautier B; Czernichow S; Hercberg S; Blacher J
    Eur J Cardiovasc Prev Rehabil; 2010 Oct; 17(5):541-8. PubMed ID: 20216318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral arterial procedures and postinterventional prophylaxis.
    Kröger K
    J Endovasc Ther; 2006 Feb; 13(1):32-8. PubMed ID: 16445321
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug treatment and cost of cardiovascular disease in Australia.
    Ademi Z; Liew D; Chew D; Conner G; Shiel L; Nelson M; Soman A; Steg G; Bhatt DL; Reid C;
    Cardiovasc Ther; 2009; 27(3):164-72. PubMed ID: 19689615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Secondary prevention of arteriosclerosis].
    Hoffmann U; Leu AJ
    Praxis (Bern 1994); 1996 Sep; 85(39):1201-5. PubMed ID: 8927904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral anticoagulant and antiplatelet therapy and peripheral arterial disease.
    ; Anand S; Yusuf S; Xie C; Pogue J; Eikelboom J; Budaj A; Sussex B; Liu L; Guzman R; Cina C; Crowell R; Keltai M; Gosselin G
    N Engl J Med; 2007 Jul; 357(3):217-27. PubMed ID: 17634457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the preventive effect of different drugs depend on location of the atherosclerotic process?
    Poredos P; Jezovnik MK
    Int Angiol; 2008 Aug; 27(4):274-80. PubMed ID: 18677288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organising a nurse-driven PAD rehabilitation clinic within the vascular surgical department: what is required and are treatment goals reached--a prospective study?
    Sillesen H; Madelung S; Eldrup N; Roed M
    Eur J Vasc Endovasc Surg; 2007 Jan; 33(1):26-32. PubMed ID: 17070079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary medical prevention among Danish patients hospitalised with either peripheral arterial disease or myocardial infarction.
    Gasse C; Jacobsen J; Larsen AC; Schmidt EB; Johannesen NL; Videbaek J; Sørensen HT; Johnsen SP
    Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):51-8. PubMed ID: 17923426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is the optimum perioperative drug therapy following lower-extremity vein bypass surgery?
    Henke P
    Semin Vasc Surg; 2009 Dec; 22(4):245-51. PubMed ID: 20006805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atherothrombosis--wave goodbye to combined anticoagulation and antiplatelet therapy?
    Mohler ER
    N Engl J Med; 2007 Jul; 357(3):293-6. PubMed ID: 17634465
    [No Abstract]   [Full Text] [Related]  

  • 15. Medical risk factor treatment in peripheral arterial disease. Need for further improvement.
    Alhadad A; Wictorsson C; Alhadad H; Lindblad B; Gottsäter A
    Int Angiol; 2013 Jun; 32(3):332-8. PubMed ID: 23711686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics and treatments of patients with peripheral arterial disease referred to UK vascular clinics: results of a prospective registry.
    Khan S; Flather M; Mister R; Delahunty N; Fowkes G; Bradbury A; Stansby G
    Eur J Vasc Endovasc Surg; 2007 Apr; 33(4):442-50. PubMed ID: 17196851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombotic therapy in peripheral arterial disease.
    Lipsitz EC; Kim S
    Clin Geriatr Med; 2006 Feb; 22(1):183-98, x. PubMed ID: 16377474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination antiplatelet therapy in patients with peripheral arterial disease: is the best therapy aspirin, clopidogrel, or both?
    Mohler ER
    Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S1-6. PubMed ID: 19213065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary medical prevention after primary vascular surgery between 1996 and 2006: a shift towards more evidence-based treatment.
    Høgh A; Lindholt JS; Nielsen H; Jensen LP; Johnsen SP
    Eur J Prev Cardiol; 2013 Oct; 20(5):763-70. PubMed ID: 22637739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal medical management of peripheral arterial disease.
    Rice TW; Lumsden AB
    Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.